Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Testing & Research Institute (KTR) is a South Korean testing, certification, and technical services organization rather than a drug-development biotech or pharmaceutical company. It provides testing, inspection, certification, regulatory support, and consulting across multiple industries, including healthcare, medical devices, chemicals, consumer products, electronics, batteries, and environmental safety. In the life sciences and healthcare context, KTR appears to operate primarily as a testing and certification partner supporting product validation, regulatory compliance, and market access rather than developing proprietary therapeutics. The organization was established in 1969 and is widely described as one of Korea’s leading testing and certification institutions, serving tens of thousands of companies annually. For biotech analysts, KTR is best understood as a commercial technical services and certification institution with healthcare relevance, especially in medical-device and regulatory testing, not as a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Testing & Research Institute.